These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27260145)

  • 1. The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease.
    Cavicchioli MG; Guerbali CC; Ochiai C; Silva RM; Camara G; Petry TB
    Curr Atheroscler Rep; 2016 Jul; 18(7):44. PubMed ID: 27260145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating diabetes: cardiovascular benefits of antidiabetes drugs.
    Harmel AP
    Am J Manag Care; 2002 May; 8(8 Suppl):S219-28; quiz S229-32. PubMed ID: 12022237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Educating patients with diabetes about cardiovascular disease risk.
    Quinn L
    Prog Cardiovasc Nurs; 2004; 19(3):107-13. PubMed ID: 15249771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of antidiabetic therapy on the risk of cardiovascular diseases and their complications in patients with type 2 diabetes mellitus].
    Ametov AS; P'ianykh OP; Chernikova NA
    Ter Arkh; 2010; 82(8):71-5. PubMed ID: 20873250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholesterol metabolism in patients with type 2 diabetes].
    Vrablík M; Tůmová E
    Vnitr Lek; 2016 Mar; 62(3):189-94. PubMed ID: 27180667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
    Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
    Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".
    Deedwania PC
    Arch Intern Med; 2010 Sep; 170(17):1575-7. PubMed ID: 20876409
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular prevention in type 2 diabetic patients: review of efficacious treatments.
    Goderis G; Boland B
    Acta Clin Belg; 2004; 59(6):329-39. PubMed ID: 15819377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular disease prevention in adults with type 2 diabetes mellitus according to the recent statement from the American Heart Association/American Diabetes Association].
    Avogaro A
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):5S-11. PubMed ID: 27030118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.
    Blonde L; Dempster J; Gallivan JM; Warren-Boulton E
    J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].
    Pedro-Botet J; Chillarón JJ; Benaiges D; Flores-Le Roux JA
    Clin Investig Arterioscler; 2016; 28(3):154-63. PubMed ID: 26655375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important aspects of self-management education in patients with diabetes.
    Stam DM; Graham JP
    Pharm Pract Manag Q; 1997 Jul; 17(2):12-25. PubMed ID: 10168174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coaching patients in compliance].
    Penfornis A
    Soins; 2006 Mar; (703 Suppl 1):1S29-30. PubMed ID: 16604816
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review.
    Vaidya V; Gangan N; Sheehan J
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):487-97. PubMed ID: 25824591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The domino effect: obesity, type 2 diabetes and cardiovascular disease.
    Green V
    Br J Community Nurs; 2005 Aug; 10(8):358-61. PubMed ID: 16116394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes and cardiovascular disease: a key role for the state diploma nurses].
    Manus JM
    Rev Infirm; 2002 Nov; (85):32-3. PubMed ID: 12510528
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.
    Cavender MA; Lincoff AM
    Am J Cardiovasc Drugs; 2010; 10(4):209-16. PubMed ID: 20653327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.